Choroidal Neovascularization Prevention Trial Planning

Fine, Stuart L.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Eye Institute (NEI)
• Type: Exploratory/Developmental Grants (R21)
• Project #: 1R21EY011275-01
• Application #: 2165594
• Study Section: Special Emphasis Panel (SRC (02))
• Project Start: 1996-02-01
• Project End: 1997-01-31
• Budget Start: 1996-02-01
• Budget End: 1997-01-31
• Support Year: 1
• Fiscal Year: 1996

Institution

• Name: Presbyterian Medical Center of Phila
• City: Philadelphia
• State: PA
• Country: United States
• Zip Code: 19104

Publications

Prenner, Jonathan L; Rosenblatt, Brett J; Tolentino, Michael J et al. (2003) Risk factors for choroidal neovascularization and vision loss in the fellow eye study of CNVPT. Retina 23:307-14

Choroidal Neovascularization Prevention Trial Research Group (2003) Laser treatment in fellow eyes with large drusen: updated findings from a pilot randomized clinical trial. Ophthalmology 110:971-8

Kaiser, R S; Berger, J W; Maguire, M G et al. (2001) Laser burn intensity and the risk for choroidal neovascularization in the CNVPT Fellow Eye Study. Arch Ophthalmol 119:826-32

Ho, A C; Maguire, M G; Yoken, J et al. (1999) Laser-induced drusen reduction improves visual function at 1 year. Choroidal Neovascularization Prevention Trial Research Group. Ophthalmology 106:1367-73;discussion 1374

(1998) Choroidal neovascularization in the Choroidal Neovascularization Prevention Trial. The Choroidal Neovascularization Prevention Trial Research Group. Ophthalmology 105:1364-72

(1998) Laser treatment in eyes with large drusen. Short-term effects seen in a pilot randomized clinical trial. Choroidal Neovascularization Prevention Trial Research Group. Ophthalmology 105:11-23